|
|
|
Insider
Information: |
Reese David M |
Relationship: |
EVP & Chief Technology... |
City: |
Thousand Oaks |
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
61,889 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$19,748,780 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
61,889 |
|
|
Total
Value |
$19,748,780 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amgen Inc |
AMGN |
EVP & Chief Technology... |
2024-05-07 |
61,889 |
2018-11-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2018-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,830 |
30,618 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2019-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,676 |
34,324 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,511 |
36,075 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2020-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,711 |
40,285 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2020-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,469 |
41,408 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,803 |
43,715 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2021-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,006 |
46,326 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,989 |
52,714 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2022-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,897 |
51,652 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,947 |
56,167 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2023-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,814 |
55,527 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP & Chief Technology Officer |
|
2024-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,407 |
66,653 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP & Chief Technology Officer |
|
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,196 |
61,889 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2019-01-30 |
4 |
D |
$192.11 |
$22,093 |
D/D |
(115) |
30,648 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2019-03-22 |
4 |
D |
$191.89 |
$339,453 |
D/D |
(1,769) |
32,752 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2019-05-01 |
4 |
D |
$179.32 |
$181,834 |
D/D |
(1,014) |
31,738 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2019-05-03 |
4 |
D |
$176.50 |
$30,711 |
D/D |
(174) |
31,564 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2020-03-09 |
4 |
D |
$210.65 |
$164,307 |
D/D |
(780) |
40,985 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2020-03-20 |
4 |
D |
$198.76 |
$368,700 |
D/D |
(1,855) |
39,338 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2020-04-27 |
4 |
D |
$236.28 |
$39,695 |
D/D |
(168) |
39,170 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2020-05-01 |
4 |
D |
$239.22 |
$250,224 |
D/D |
(1,046) |
38,124 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2020-05-03 |
4 |
D |
$230.98 |
$42,731 |
D/D |
(185) |
37,939 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2020-11-02 |
4 |
D |
$216.94 |
$460,998 |
D/D |
(2,125) |
39,619 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2021-02-16 |
4 |
D |
$237.21 |
$272,080 |
D/D |
(1,147) |
40,912 |
0 |
- |
|
AMGN |
Amgen Inc |
EVP, Research and Development |
|
2021-03-19 |
4 |
D |
$244.42 |
$342,432 |
D/D |
(1,401) |
42,494 |
0 |
- |
|
45 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|